Cultura de tecido ovárico humano congelado: efeito da Activina A e GDF9 by Anastácio, Amandine Isolina
 Universidade de Aveiro  
2009 
Departamento de Biologia 
Amandine Isolina 
Anastácio 
 
Cultura de Tecido Ovárico Humano Congelado: 
efeito da Activina A e GDF9 
 
Culture of Human Cryopreserved OvarianTissue: 
effect of Activin A and GDF9 
 
  
 
 Universidade de Aveiro  
2009 
Departamento de Biologia 
Amandine Isolina 
Anastácio 
 
Cultura de Tecido Ovárico Humano Congelado: 
efeito da Activina A e GDF9 
 
Culture of Human Cryopreserved Ovarian Tissue: 
effect of Activin A and GDF9 
 
 dissertação apresentada à Universidade de Aveiro para cumprimento dos 
requisitos necessários à obtenção do grau de Mestre em Biologia Molecular e 
Celular, realizada sob a orientação científica du Docteur Catherine Poirot, 
Professeur de la Faculté de Médecine, Paris VI, Pierre et Marie Curie e da 
Doutora Maria de Lourdes Gomes Pereira, Professora Associada com 
agregação do Departamento de Biologia da Universidade de Aveiro 
 
 
 
 
 
  
 
 
 
 
 
 
o júri   
 
presidente Prof.ª. Doutora Maria Helena Abreu Silva 
Professora Auxiliar do Departamento de Biologia da Universidade de Aveiro 
 
 Prof.ª. Doutora Ana Teresa de Almeida Santos  
Professora Auxiliar da Faculdade de Medicina de Coimbra 
 
 Prof.ª. Doutora Catherine Poirot 
Professeur de la Faculté de Médecine Paris VI, Pierre et Marie Curie 
 
 Prof.ª. Doutora Maria de Lourdes Gomes Pereira 
Professora Associada com Agregação da Universidade de Aveiro 
 
  
  
  
  
  
  
  
  
  
 
 
 
 
  
  
 
agradecimentos 
 
Au Professeur Catherine Poirot, pour m’avoir fais confiance encore une fois et 
de continuer à m’orienter dans mon travail, à sa disponibilité et son 
enthousiasme pour mon travail. Merci encore de me permettre de travailler 
avec vous et votre équipe. 
 
Aux Docteurs Marie Prades et Benoit Schubert, pour leur amitié et leur soutien. 
 
A Aurélie, Leslie, Monia et Nicolas pour tous ces moments de détente 
partagés. 
 
A toute l'équipe de l'UF de Biologie de la Reproduction de la Pitié-Salpêtrière
pour m’avoir aussi bien accueille au sein de leur petite «famille». 
 
A la Fondation Martine Midy qui a permis la réalisation de ce projet en me 
finançant. 
 
A ma sœur de coeur et d’esprit, Sandrine, pour me tolérer encore chez elle 
malgré ma mauvaise humeur, de comprendre même mes silences, pour toutes
les heures passées à m´écouter et à me conseiller.  
 
Aos meus pais, por tudo o que fizeram para que eu pudesse seguir os meus 
sonhos e por me terem encorajado mesmo estando tão longe. 
 
Aos meus irmãos, obrigada por estarem sempre presentes e pelos abraços 
que me dão força para voltar. 
 
Ao Renato por nunca se negar a dar resposta às minhas perguntas, mesmo as 
menos pertinentes.  
 
Ao Jacinto um obrigada muito especial pela Amizade, tolerância e força que 
me tem dado para a concretização deste projecto. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
palavras-chave Crioconservação/ Cultura tecido Ovárico/ Activina A/GDF9 
 
resumo 
 
 
A crioconservação de tecido ovárico é um dos métodos utilizados para 
preservar a fertilidade de mulheres em risco de menopausa precoce, devido a 
tratamentos gonadotóxicos. 
O tecido ovárico crioconservado contém essencialmente oócitos imaturos, não 
fecundáveis, sendo por isso necessário induzir a sua maturação. A maturação 
dos oócitos contidos no tecido ovárico crioconservado pode ser realizada 
transplantando o tecido (in vivo) ou procedendo à sua cultura (in vitro), tema 
deste trabalho. 
Este trabalho foi desenvolvido para avaliar a morfologia e a evolução dos 
folículos ováricos contidos no tecido, recorrendo a três marcadores de 
qualidade celular [dois marcadores da apoptose (p53 e Bcl2) e um marcador 
de proliferação celular (Ki67)], sem matriz de suporte, em três meios de cultura 
distintos durante 14 dias. 
Este estudo comparativo foi realizado utilizando um meio de cultura base, 
também usado como grupo de controlo, ao qual se adicionaram, 
individualmente, duas proteínas pertencentes à Tranforming Growth Factors 
superfamily, GDF-9 e Activina A. 
Neste trabalho, verificou-se uma diminuição da população folicular ao longo da 
cultura para os três meios utilizados.  
No entanto, a maior proporção de folículos degenerados foram observados no 
grupo em cultura com Activina A contrapondo com o grupo em cultura com 
GDF-9 onde se observou a menor percentagem de folículos degenerados. 
Nos três meios de cultura utilizados apenas se observaram três tipos de 
folículos (primordial, early primário e primário). 
Verificou-se uma marcação positiva para os marcadores p53 e Ki67 em todos 
os meios e ao longo da cultura. Para o marcador Bcl2 não foi observada 
nenhuma célula da granulosa marcada positivamente. 
Com este trabalho verificamos uma melhor taxa de sobrevivência no grupo 
GDF-9, assim como um maior número de folículos e células da granulosa nos 
primeiros 10 dias de cultura. 
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abstract 
 
Cryopreservation of ovarian tissue is one approach to preserve fertility of 
young women who are at risk of premature ovarian failure, due principally to a 
gonadotoxic treatment. 
The cryopreserved ovarian tissue has essentially immature oocytes, which
need to be maturating for ulterior fertilization.  
Oocyte maturation can be achieved by transplantation or by maturation in vitro, 
which was the subject of this work. 
The present work was developed to evaluate the morphology and evolution of 
follicles using three markers of cellular quality [two apoptotic markers (p53 and 
Bcl2) and one proliferating marker (Ki67)] during 14 days of culture for three 
different culture media, without matrix support.  
For this comparative study we used a serum free medium (control group) to 
which we added two proteins from the Transforming Growth Factors 
superfamily Activin A and GDF-9. 
A diminution of the follicular population was observed throughout the culture 
and for all the culture media. However, the higher proportion of degenerating 
follicles (increasing with the time of culture) were observed at the Activin A
group (A) and GDF-9 group (G) representing the lower proportion.  
For the three culture media only three type of follicles were seen (primordial, 
early primary and primary). 
All GCs in the three culture media were negative for Bcl2 immunostaining. . 
Positive marking were observed for the apoptotic marker (p53) and for the 
proliferating marker (Ki67) in all culture.  
This study indicate a better survival in the group cultured with GDF-9, a higher 
number of follicles and cells of the granulosa in the first 10 days of culture 
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INTRODUCTION 
 Women have a finite number of follicles that sustain ovarian function until the 
menopause. Any situation affecting the follicles pool can induce a premature ovarian 
failure. This failure can be caused by genetics disorders and more commonly as a 
consequence of anticancer treatments exposure, being extremely important to propose 
methods to preserve their fertility. 
One approach to preserving the potential fertility of young women who risk 
losing their follicles reserve is the cryopreservation of ovarian tissue containing 
immature oocytes. 
The cryopreserved tissue can be transplanted into the pelvic cavity (orthotopic) 
or in a heterotopic site such the abdominal wall or the forearm. However in some types 
of cancer the transplantation has a high risk of reintroduce malignant cells, 
subsequently is very important to study and develop alternative methods such as the 
maturation in vitro of the follicles and their oocyte. 
Over the last two decades, culture systems have been developed with the aim of 
growing follicles from the earliest stage into maturation of the oocyte and fertilization.  
In mice offspring it has already been obtained with maturation of primordial 
follicles and their fertilization in vitro but in Human this process reveals being more 
complex due to the long time needed for the folliculogenesis, the little knowledge of 
the factors involved in the initiation of the growth of small follicles and the dense 
structure of the ovarian tissue.  
 Nevertheless a number of factors produced in the ovary itself, as the 
Transforming Growth Factor beta family, are known to control the initiation of the 
growth of small follicles. 
 At present time, it is known that the GDF-9 plays an important role in the 
initiation of the growth of small follicles as well as the survival of these throughout the 
culture while activin A seams to promote the growth and development of secondary 
follicles to antral follicles. 
 The aim of our study was to analyze the effects of growth differentiation factor 
9 and activin A during the culture of human cryopreserved ovarian tissue, since to date, 
the published studies show results obtained essentially with culture of fresh ovarian 
tissue, using morphological characteristics, apoptotic markers (p53, Bcl2) and 
proliferating marker (Ki 67).  
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REVIEW OF THE LITERATURE 
THE OVARY 
The ovary is the reproductive organ in female mammals, it measures about 4 cm 
long, 2 cm wide, 1 cm of thick and has a dual role of gonad and endocrine gland.  
Usually, each woman has two ovaries located in the pelvic zone, one in the right side 
and the other in the left side of the uterus to which they are attached by a fibrous cord 
called the ovarian ligament.  
The outermost layer of the ovaries is the germinal epithelium constituted by 
simple cuboidal cells. Underneath this, a layer of dense connective tissue constitutes 
the tunica albuginea and covers the ovarian cortex. 
In the cortex, we found the ovarian follicles and between them the stroma, a 
peculiar soft tissue consisting mainly of connective tissue enriched with blood vessels. 
The innermost layer of the ovary, called medulla, is essentially loose connective tissue 
with abundant blood vessels, lymphatic vessels and nerve fibers (Fig.1). 
The ovary performs several tasks that include the production, storage and 
nurturing of the oocytes and segregation of hormones that promote follicle/oocyte 
maturation and development of secondary sex characteristics.  
 
Figure 1: Schematic representation of a ovary showing its internal configuration, and the different 
types of follicles (Adapted from http://academic.kellogg.cc.mi.us) 
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OVARIAN RESERVE 
 In Humans, the follicular reserve is mainly comprised of primordial follicles, 
containing an oocyte I, and begins to form at the fourth month of fetal life (Baker, 
1963), around the 20 weeks of gestation, about seven millions of oocytes are formed in 
each ovary, and it is believed those are all the oocytes that woman will ever have. At 
birth the reserve drops to one to two millions and at the onset of puberty only 300 000 
to 400 000 remain (Baker, 1963; Faddy et al., 1992; Faddy, 2000). From there, the 
number of follicles gradually decreases until the age of 37-38 years old, when rapidly 
drops and ends in menopause several years later with only 1000 follicles in each ovary 
(Faddy et al., 1992). However, during reproductive life of a woman, only 400 follicles 
mature and ovulate (Gougeon, 1996), whereas the remainders go through atresia and 
degenerates. 
  
  
 The depletion of the ovarian stock occurs as a result of two major processes: 
atresia, by apoptosis, and entry in growth phase. In the Human the depletion before 
puberty and after 30 years of age is mainly due to atresia whereas between those ages 
this follicles loss is due to entrance of resting follicles in growth phase (Gougeon, 1996).  
 
Figure 2 : Diagram of ovarian reserve and outcomes of the formed follicles throughout women life 
    (adapted from Kaipa & Hsueh, Annu Rev Physiol 1997, 59:349-63) 
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OOGENESIS AND OOCYTE MATURATION 
 The oogenesis starts with the formation on the oogonia and involves several 
processes that lead to their development and maturation. 
 The oogonia are originated from primordial germ cells (PGC) in a common path 
of gametogenesis in females and males.  
 At the end of the third week of development PGC’s migrate from the primary 
ectoderm into the yolk sac (Baker et al., 1963). Between the fifth and the sixth weeks, 
under the influence of cytokines such as Kit-ligand (KL) and transforming growth factor 
β (TGFβ), these cells continue to migrate until they reach the genital ridge, where they 
stay and colonize the developing gonads, by mitosis (Motta and Makabe, 1986).  
 After colonization, around the seventh week of gestation, the sex specific 
differences appear and the germ cells differentiate into oogonia or spermatogonia 
according to chromosomal constitution and the environment in which they develop. 
Henceforth oogonia continue to undergo mitosis and stimulate cells of the adjacent 
epithelium to form follicular cells (Faddy et al., 1992), but around the eleventh week of 
development they enter in meiosis and stop in the prophase of the first meiotic division, 
becoming oocytes I. At the same time, they became enclosed in one layer of 
pregranulosa cells surrounded by a basal membrane forming a complex called primordial 
follicle (Gosden and Bownes, 1995). The nucleus of these dormant oocytes I becomes 
very large and it is called a germinal vesicle (GV). 
When the follicle is recruited for the 
growing pool the oocyte undergoes an 
important increase of volume from 35µm in 
primordial follicle to 120µm in a fully developed 
follicle (Gougeon, 1996; Picton et al., 1998) 
associated with the follicular growth. However 
the oocyte I persists in prophase of the first 
meiotic division until the time of ovulation, 
when meiosis is resumed and the first polar 
body is formed and extruded, becoming a 
fertilizable oocyte. This oocyte is arrested in the 
metaphase of meiosis II and only completes his 
second meiotic division after fertilization (Fig 3). 
Oocyte arrested 
in prophase I 
(Oocyte I) 
Oocyte arrested at  
metaphase of meiosis II  
(Oocyte II)  First polar   
body 
Second polar 
body 
Fertilization and 
 completation of 
meiosis II 
Growth and 
completation of 
meosis I 
Figure 3 : Meiosis of oogonia (adapted from Pearson 
   education Inc.,  publishing as Benjamin       
   Cummings) 
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The fully and competent maturation of the oocyte depends on two crucial 
events, the long and imperceptible cytoplasmic maturation and the short and clearly 
observable nuclear maturation. 
Cytoplasmic maturation 
Cytoplasmic maturation includes accumulation of mRNAs and proteins, 
cytoplasmic reorganization and epigenetic modifications, necessary to prepare the 
oocyte for fertilization and normal embryo development, and it is divided in two major 
events, the acquisition of competence to development (before resumption of meiosis) 
and the oocyte activation prior to ovulation. 
During the oocyte growth, an extensive production and reorganization of the 
cytoplasm takes place. At this period, the oocyte stores glycogen granules, lipid 
droplets and proteins likely to provide energy and substrate to the formation of new 
membranes after fertilization (Picton et al., 1998), the number of mitochondria 
increases drastically and become more vacuolated, sign of loss activity (Wassarman and 
Josefewicz, 1978) as well as the number of ribosome, important to the accumulation of 
mRNA and proteins. 
As the oocytes get larger organelles migrate to the periphery of the oocyte, the 
Golgi apparatus enlarges and becomes active in secreting proteins to the production of 
the zona pellucida (Mehlmann et al., 1995) and the endoplasmic reticulum forms more 
cortical distribution where it facilitates the exocytosis of cortical granules by releasing 
calcium.  
During oocyte maturation a large quantity of RNA is stored in the cytoplasm. In a 
human immature oocyte there is 2 ng of RNA (Neilson et al., 2000) of which 8% is mRNA, 
a bigger quantity than in a somatic cell (Gosden, 2002). Throughout maturation mRNA is 
degraded and in a mature human oocyte there is 40% less mRNA than in an immature 
oocyte (Dobson et al., 2004). The synthesis and expression of the mRNA are controlled 
by a complex system and depends on when during the maturation process they are 
needed (Bachvarova, 2002). 
The oocyte activation designs the ultrastructural modifications occurred in the 
oocyte just before the ovulation, which are essential for his capacity to be fertilized 
and to develop embryo (Hyttel et al., 1997). Thus, in this oocyte, a diminution of the 
size of the Golgi apparatus, an increase of the number of lipid vesicles and a regrouping 
of cortical granules is observed (Cran, 1985). 
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Nuclear maturation 
During meiotic division, the genetic material is halved completing two nuclear 
divisions, but only a single replication of the nuclear DNA. 
The immature oocyte is blocked at the diplotene stage of the first meiotic 
division, and his nucleus is called GV. 
The nuclear maturation is characterized by the germinal vesicle break down 
(GVBD) and the cells enters metaphase I (MI) and progresses with meiosis until it is 
arrested once again, in the metaphase II (MII) and the first polar body is extruded. At 
this stage, the oocyte can be fertilized. When the oocyte is fertilized it restarts meiotic 
division and completes its maturation with the expulsion of a second polar body. 
FOLLICULOGENESIS AND STAGES OF FOLLICULAR DEVELOPMENT 
 Follicles, the basic functional units of the ovary, are comprised in two functional 
pools, resting and growing follicles. It’s from the resting pool that follicles will be 
recruited for maturation throughout life.  
 The recruitment is regulated by paracrine and autocrine signals produced in the 
ovary itself, while proliferation and differentiation are controlled by internal signaling 
and endocrine signals from outside the ovary (Thomas et al., 2003).  
 By unknown reasons, follicles are gradually and continuously recruited and start 
to growth, unfortunately, the factors and hormones which stimulate or inhibit this 
process remain to be identified. Even if gonadotrophins receptors were identified at this 
stage (Bao and Garverick, 1998), this initial growth appears to be independent of 
pituitary gonadotrophins since the primordial follicles can still develop to the early 
antral stage in their absence (Awotwi et al., 1984; Gong et al., 1996). Others studies 
indicate that maybe several members of the growth factor beta superfamily are 
implicated (Erickson GF and Shimasaki S, 2001; Reddy et al., 2008; Trombly et al., 
2009). 
The quiescent follicle consists of an immature oocyte surrounded by a single 
layer of flattened granulosa cells and it is called primordial follicle (Gougeon, 1996) 
and measure approximately 30µm.  
When these follicles are recruited into the growing pool, the granulosa cells grow 
and become cuboidal but continuous to form only one layer – primary follicle, this 
appearance is the first sign of activation and initial recruitment. The granulosa cells of 
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Figure 4: Human ovarian follicles at the primordial stage (A), 
    the primary stage (B),the secondary stage (C) and   
    the antral stage (D) 
    (by Gougeon in the photothèque fertilité Ferring®) 
 
this follicle, that measure now approximately 60 µm, start to secrete 
mucopolysacharides around the oocyte to form the zona pellucida.  
The granulosa cells proliferation forming multiple layers around the oocyte, and 
oocyte size increasing, are the secondary or pre-antral follicle characteristics. When 
there are three or more layers of granulosa cells, the surrounding stromal cells 
differentiate to form theca interna and theca externa, with vessels blood between it 
(Reynolds et al., 1992). At this stage the diameter of the follicle is 100-200 µm and 
granulosa cells demonstrate very high mitotic activity. Once the follicle reaches a 
specific size, approximately 500 µm, it stars to develop a space fluid filled within 
granulosa cells called antrum (Telfer and Gosden, 1987) and become acutely dependent 
on gonadotrophins for further growth and development (Nayudu and Osborn, 1992) – 
antral follicle. At this stage the granulosa cells differentiate to mural granulosa cells, 
forming a thin layer along the periphery of the follicle, and to cumulus granulosa cells 
that surround the oocyte, forming the pre-ovulatory follicle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As soon as the follicle enters the growing pool the oocyte starts to grow and 
communicate with the surrounding follicular cells, which communicate each other, 
through gap junctions (Eppig, 1982). The gap junctions allow the bidirectional transfer 
of nutrients, metabolic precursors and signal molecules (Eppig, 1991; 1992). 
  This interaction is the essential factor for the oocyte and follicular development. 
A 
D C 
B 
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APOPTOSIS 
 Contraction followed by clumping of the chromatin, wrinkling of the oocyte 
nuclear membrane and dislocation of the granulosa cells (GC’s) is considered signs of 
atresia (Baker, 1963). This atresia condition is the result of an apoptotic process that is 
morphologically characterized by condensation of nuclear chromatin, nucleolus 
disintegration and a reduction of nuclear size, simultaneously with cytoplasmic 
condensation and reduction of the total cell volume. 
 The activation of apoptotic cascade in follicles, among others, can be due to 
oxidative stress, insufficient tropic support and chemical messengers. All these 
alterations lead to the 
activation of endonucleases 
activity and disrupt prevailing 
ionic gradients, causing DNA 
damage.  
  
 The DNA damage is a 
stimulus for increased p53 
expression in GC’s inducing the 
arrest of cell proliferation 
blocking it at G1 phase. This 
cell cycle arrest is reversible, 
and if the appropriate DNA 
repair is done, the p53 
decrease and cell cycle 
continues, otherwise cell dies 
(Fig 5). 
 This process can also 
been prevented among others 
by Bcl2, that acts as 
antioxidant, blocking the cell 
death pathway, but is not 
associated to cell proliferation. 
  
Figure 5: Diagram of p53 apoptosis pathway (“+”= stimulation; 
“-“= inhibition; Mit= mithocondria)   
               (adapted from Gillham et al. World Journal of 
Surgical Oncology 2007)   
Bax 
Bcl2 
DNA DAMAGE 
p53 
G1/S and G2/M cell 
cycle arrest 
+ 
- 
+ 
CELL CYCLE 
- 
+ Mit 
Cytochrome C 
release 
Caspase 9/3/7 
APOPTOSIS 
+ 
+ 
+ 
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Briefly, the fate of GC’s during development may be decided by the balance of 
death repressors and death inducers. 
 The proliferation of GC’s is essential to follicle and oocyte development, being 
an important way to evaluate their viability. The proliferating status can be proved by 
the expression of Ki67 that is expressed in all phases of cell cycle excepting G0 phase. 
TRANSFORMING GROWTH FACTOR ΒETA SUPERFAMILY 
Among the many growth factors that have been identified as being important in 
early follicular growth several are members of the Transforming Growth Factor-β 
superfamily (Erickson and Shimasaki, 2000). 
The TGF-β superfamily is a large group of 25kDa proteins, which share commons 
structural motifs (Chang et al., 2002). They are all synthesizes as prepropeptides with 
one signalpeptide, a large proregion and a smaller biologically active mature region, 
and exists as homo or heterodimers (Massagué, 1990; Chang et al., 2002). They are 
categorized into 23 distinct gene types that fall into four major groups, i.e., bone 
morphogenetic proteins and growth differentiation factors; activins and inhibins; TGF-β 
itself and a group encompassing various divergent members as anti Mulerian hormone 
(AMH) (Burt, 1992; Herpin et al., 2004).  
Two types of transmembrane serine/threonine kinase receptors (Type I and Type 
II) have been identified for these polypeptides (Massagué and Wotton, 2000; Chang et 
al., 2002; Miyazawa et al., 2002). When a ligand binds, the kinase of the type II 
receptor phosphorylate and thereby activates the kinase of the type I receptor, which in 
turn will activate the intracellular signaling molecules called Smad proteins  (Shi and 
Massagué, 2003; ten Dijke and Hill, 2003; Caestecker, 2004). There are eight distinct 
Smad proteins known, divided in three functional classes, which are, receptor regulated 
Smads (Smad 1,2,3,5,8), collaborating Smads (Smad 4) and inhibitory Smads (Smad 6,7) 
(Shi and Massagué, 2003). 
There are basically two main pathways, the TGF-β/activin pathway where the 
ligand has a higher affinity for the type II receptors and the BMP pathway with ligands 
that have a higher affinity for the type I receptor (Shi and Massagué, 2003; Caestecker, 
2004; ten Dijke and Hill, 2004). The TGF-β/activin pathway induce the activation of 
Smads 2/3 while the BMP pathway activate the Smads 1/5/8, however both pathways 
lead to the formation of the complex regulated Smad actived/collaborating Smad (Smad 
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4) (Zhang and Derynck , 1999). This complex then translocates into the nucleus and 
activates transcription of specific genes (Zhang and Derynck, 1999). The Smads 6/7 can 
inhibit the Smads of the BMP pathway while the Smads of the TGFβ/activin pathway 
only are inhibiting by the Smad 7 (Massagué, 1998; Miyazawa et al., 2002) (Fig 6). 
 
 
 
GROWTH DIFFERENTIATION FACTOR-9 
This growth factor was identified in 1993 (McPherron and Lee, 1993) and is 
expressed and secreted by the oocytes in mostly species, including humans (McGrath et 
al., 1995). 
Mutations in the GDF-9 gene are associated with various reproductive 
abnormalities, among the most serious is that although the oocytes grow in their 
follicles, the growth of the follicular cells is retarded which results in an arrest in the 
follicle growth and infertility (Carabatsos et al., 1998), proving its essential role during 
follicular development (Dong et al., 1996). 
The expression of this factor differs among the species with GDF-9 expression 
observed in primordial follicles of sheep, cattle, possum and hamster (Bodensteiner et 
Figure 6 : The BMP and TGFβ/activin signaling pathway 
     (adapted from http://www.rr-research.no) 
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al., 1999; Eckery et al., 2002; Wang and Roy, 2004) and in primary follicles in rats, mice 
and humans (Laitinen et al., 1998; Jaatinen et al., 1999). 
This protein function as a paracrine factor in the regulation of granulosa cell 
proliferation and differentiation (Elvin et al., 1999; Eppig, 2001; Gilchrist et al., 2006), 
and is correlated with recruitment of follicles for growth being essential for fertility 
(Dong et al., 1996). The higher proportion of viable human follicles in organ culture, 
suggest that this factor enhances the survival of the follicles (Hreinsson et al., 2002). 
The role of GDF-9 in each stage of follicular development remains unclear but 
several studies pointed to its extreme importance for the proper development of 
follicle/oocyte (Dong et al., 1996; Elvin et al., 1999; Hanrahan et al, 2004; Kovanci et 
al., 2007), becoming crucial to understand his action mechanism .  
ACTIVIN A 
Activins are hetero or homo dimmers comprising two different beta subunits (A 
or B) with activin A being the predominant activin isoform. In the ovary, activins are 
produced by the GC’s and are important in folliculogenesis (Findlay et al., 2002), but 
the exact stages of development that activin A regulated are unclear. However, it has 
been shown to promote follicle growth by increasing GC proliferation and enhancing 
antral formation (Mizunuma et al., 1999; Zhao et al., 2001).  
Activin stimulated follicle in vitro has been demonstrated in preantral ovine 
follicles (Thomas et al., 2003), caprine follicles (Silva et al., 2006), rodent follicles 
(McGee et al., 2001) and in human follicles (Telfer et al., 2008). Furthermore, it has 
been observed in vitro that activin A stimulates the meiotic maturation of the oocytes 
in human, rat and rhesus monkey (Itoh et al., 1990; Sadatsuki et al., 1993; Alak et al., 
1998). 
There is no evidence for the role of activin A in primordial follicle activation, but 
his expression on this early stage is a reason to think that it can have a relevant role at 
this stage (Mizunuma et al., 1999), thus, further investigations will be necessary. 
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FERTILITY PRESERVATION 
The survival rate of children and young women after treatment against malignant 
diseases has increased in the last decades, due to improvements in the treatment 
therapies (Landis et al., 1998). Nevertheless one of the side effects of these treatments 
(chemotherapy/radiotherapy) is the frequent loss of fertility and the onset of a 
premature ovarian failure (POF) ((Donnez et Bassil, 1998; Yeung et al. 1998; Smitz et 
Cortvrindt, 1999).  
The ovaries are very sensitive to cytotoxic treatment, especially to alkylating 
agents that increase the risk of POF by a factor of 9 (Byrne et al., 1992).  
For the abdominal radiation it has been stated that a dose of 5-20 Gy is 
sufficient to completely impair gonadal function (Wallace et al., 2005), moreover, the  
association of abdominal radiation and chemotherapy with alkylating agents could 
rendering patients infertile in almost 100% of the cases (Donnez et al., 2006).  
Beyond cancer and autoimmune diseases treatments such as radiotherapy or 
chemotherapy POF can be induced by chromosomal abnormalities such Turner’s 
syndrome (characterized by partial or total loss of one of the X chromosomes) (Sylven et 
al., 1993) and gene defects such as FSH receptor mutations (Aittomaki et al., 1995). 
Thus it is important to develop options for fertility preservation for these women. 
 Currently, there are three options proposed for fertility preservation: embryo 
cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation (Gosden, 
2005; Meirrow et al., 2005). Nevertheless the choice of the most convenient strategy for 
preserving fertility depends on the type of the disease, the patient’s age and in some 
countries their partner status. 
EMBRYO CRYOPRESERVATION 
This technique is the most widely available because she has become a routine in 
all Assisted Reproductive Technology (ART) centers and has proven its efficacy in terms 
of pregnancy and rates of delivery babies. However there are several drawbacks to the 
application of this technique.  
First it is only applicable to post pubertal patients, who have a partner or, status 
law depending, are willing to use donor sperm.  
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Secondly, the In Vitro Fertilization (IVF) needs a cycle of hormonal stimulation 
for about a month that can represent an unacceptable delay to the beginning of the 
treatment, and at last, if the patient has a hormonal-sensitive tumour the traditional 
ovarian stimulation may be harmful.  Recently, tamoxifen and letrozole were proposed 
as a safe alternative to the traditional ovarian stimulation (Oktay et al., 2005). 
OOCYTE CRYOPRESERVATION 
Oocyte cryopreservation is an alternative for patients with the same 
characteristics as those described to the embryos but who are not with a partner and/or 
do not wish, or can not use sperm donation. The oocyte cryopreservation can be doing 
at the mature or immature state but there are different advantages and inconveniences 
associated with each state. 
Mature oocyte 
The metaphase II (MII) oocyte is a large and highly specialized cell that is 
extremely fragile due, among other things, to the spindle apparatus that is easily 
damaged by intracellular ice formation (Mandelbaum et al., 2004) inducing a risk of loss 
of chromosomes.  
Several years after the first report of a live birth after cryopreservation of 
matures oocytes and thawing followed by IVF (Chen et al., 1986) the success rate 
remained low, but the combination with intra cytoplamisc sperm injection (ICSI) slightly 
improved the success rate (Porcu et al., 1997; Fabbri et al., 2001) since it avoid the 
difficulty of the spermatozoas to penetrate the zona pellucida hardened during the 
freezing process.  
 Improvements of the freezing protocols such the concentration of 
cryoprotectants (Fabbri et al., 2001), the time of exposure to pre-equilibration and 
thawing (Yang et al., 2002) also improved the survival rate of the mature oocytes after 
thawing (Sonmezer and Oktay, 2004), however, the mean pregnancy rate per thawed 
oocyte does not exceed 1.8% (Borini et al., 2006. Levi Setti et al., 2006). 
 Recently the ultrarapid freezing with vitrification offer advantages over 
conventional slow cooling protocols by improving post-thawing survival rates avoiding 
the formation of intracellular ice. A study demonstrates a rate of 5.1% live birth per 
warmed oocyte after vitrification (Kim et al., 2009). 
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Immature oocyte 
This oocytes at the GV stage, survive better to the cryopreservation procedure 
(Boiso et al., 2002) but there maturation in vitro is still suboptimal with only one live 
birth reported (Tucker et al., 1998).  
OVARIAN TISSUE CRYOPRESERVATION 
This is the only technique that can be proposed to children and patients who 
need immediate chemotherapy (Poirot et al., 2007).  
Cryopreservation of ovarian tissue is considered a promising method for 
preservation fertility due to the large number of immature oocytes existing in the 
ovarian cortex. 
After the first studies with animals in the 1950s (Parkes et al., 1953) and 
offspring obtaining in mice after transplantation (Parrott, 1960) the revival of the 
interest in cryopreservation of follicles in ovarian cortical tissue was in the 1990s. 
 The first human ovarian tissue cryopreservation was in 1996 (Hovatta et al., 
1996; Newton et al., 1996) using different cryoprotectants to prevent the ice crystals 
formation in the cells. The cryoprotective agents commonly used are dimethyl sulfoxide 
(DMSO) and propanediol (PrOH) or ethylene glycol (EG) at 1.5M with sucrose 0.1M 
(Hovatta et al., 1996; Newton et al., 1996; Gook et al., 1999). No significant differences 
have been observed between DMSO, PrOH in terms of follicle survival (Newton et al., 
1996). 
The follicles are cryopreserved embedded in the ovarian tissue using a 
controlled-rate cooling followed by storage in liquid nitrogen at -196°C. The tissue is 
previously divided into small fragments to facilitate the permeation of the 
cryoprotectant.  
 Studies concerning follicular viability report that at least 70% of the follicles can 
be expected to survive the process of cryopreservation and thawing (Hovatta et al., 
1996; Oktay et al., 1997; Gook et al., 1999; Cortvrindt and Smitz, 2001; Nisolle et al., 
2000). 
 The quiescent primordial follicles are the most able to survive due to their size 
and low number of granulosa cells being easily equilibrate with the cryoprotectant. 
Those follicles have a low metabolic rate, the zona pellucida is not yet formed and their 
oocyte is arrested in the prophase of the first meiotic division (Shaw et al., 2000). 
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Recently, vitrification was proposed as an alternative procedure to slow 
cryopreservation. This technique uses a high concentration of cryoprotective agents and 
an immediate freezing, transforming the aqueous parts of the cells in a solid amorphous 
vitreous stage and avoids the formation of ice crystals. 
 
The handicap of those options is that the follicles surviving the cryopreservation 
process contain immature oocytes. These oocytes can not be immediately fertilized, 
they need further maturation. This maturation can be achieved in vivo by 
transplantation or in vitro by culture of the ovarian tissue. 
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FERTILITY RESTORATION 
OVARIAN TISSUE TRANSPLANTATION 
This is to date the most viable utilization of the ovarian cryopreserved tissue 
allowing reestablishing the hormonal balance and thereby delay menopause and also 
restore fertility.  
The transplantation can be done in its original site (orthotopic), in a well 
vascularized site in the woman body (heterotopic) and to another species 
(xenotransplantation). 
The viability of this technique was demonstrated with offspring obtained in 
animals and in humans. 
Heterotopic transplantation 
This technique involves the transplantation of the tissue to another part of the 
body as the forearm (Oktay et al., 2001) or the abdomen wall (Oktay et al., 2004). With 
these options the women resumed normal menstrual cycle avoiding the hormone 
replacement therapy and oocytes have been obtained. Nevertheless, this technique 
didn’t result in evolutive pregnancy but it was shown for the first time that oocytes and 
embryos could be obtained from cryopreserved/thawed ovarian tissue, in human (Oktay 
et al., 2004). 
Orthotopic transplantation 
In this case the tissue is implanted at its original site. The first human 
transplantation was reported by Oktay and Karlikaya (2000), who obtained ovarian 
function after sixteen weeks and even an ovulation after stimulation. This study proved 
that the cryopreservation protocol was not totally harmful for human ovary. 
The first live human birth was obtained in 2004 (Donnez et al., 2004) in a patient 
without previous treatment before the cryopreservation. This, open the discussion of 
the really nature of the pregnancy; “oocyte from the remaining ovary or from the 
transplantation?”. But the next year it was published that a health child was born after 
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orthotopic transplantation of slices of ovary cryopreserved after a cancer treatment 
(Meirow et al., 2005). 
Since twenty four transplantations were reported and eight pregnancies obtain 
with six babies born. 
Xenotransplantation 
This technique is commonly done for viability studies and not as a clinical option. 
The studies, using immunodeficient mice, show good recovery of follicles and follicular 
growth to late and antral stages (Newton et al., 1996; Gook et al., 2001; Kim et al., 
Table 1 : Autotransplantations of cryopreserved human ovarian tissue  
              (adapted from Poirot et al., 2008)  
REFERENCE 
AGE 
BEFORE 
FREEZING 
GRAFT TYPE OUTCOME 
Oktay K (2000)  29 Orthotopic FD after stimulation 
Radford J (2001)  36 Orthotopic Ovarian function 
Callejo J (2001)  47 Heterotopic Endocrine ovarian 
function 
Oktay K (2004)  30 Heterotopic Embryo 
Tryde Schmidt KL (2004)  32 Orthotopic MII oocyte 
Donnez J (2004) 25 Orthotopic Live birth  
Kim S (2004)  37 Orthotopic Ovarian function 
Meirow D (2005)  28 Orthotopic Live birth 
Schmidt KL (2005)  28 
25 
32 
Orthotopic & Heterotopic 
Orthotopic & Heterotopic 
Orthotopic 
Ovarian function  
Embryo 
Embryo 
Wolner-Hanssen P (2005)  30 Heterotopic FD after stimulation 
Donnez J (2006)  21 Orthotopic Ovarian function 
Rosendhal M (2006)  28 Orthotopic & Heterotopic Pregnancy 
Demeestere I (2006) 24 Orthotopic & Heterotopic Pregnancy 
Demeestere I (2007)  24 Orthotopic & Heterotopic Live birth 
Donnez J (2008)  22 
28 
22 
Orthotopic Oocytes 
Cycles 
Cycles 
Andersen CY (2008)  26 
27 
36 
25 
Orthotopic 
Orthotopic 
Orthotopic 
Orthotopic & Heterotopic 
Live birth  
Live birth  
Ovarian function 
Silber SJ (2008)   Orthotopic Live birth 
FD – follicular development ; MII oocyte – oocyte in metaphase II 
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2002). Ovulation and the formation of corpus luteum has also been observed with this 
technique (Gook et al., 2003). 
OVARIAN TISSUE CULTURE 
For some diseases, the transplantation of the thawed fragments of ovarian tissue 
represents a high risk of reintroducing malignant cells (Shaw et al., 1996; Gosden et al., 
1997; Aubard et al., 1999). The maturation of the follicles in vitro could avoid this risk.  
The development of primordial follicles to an antral stage and consequent oocyte 
maturation is a complex procedure and until now, completely successful only in mice 
with live offspring born (Eppig and O’Brien, 1996; O’Brien et al., 2003). 
In Humans the in vitro development, with or without cryopreservation of ovarian 
tissue was reported but with fewer results than those observed in rodents, but still 
hopeful for further investigation. The complete follicular development was not yet 
report, but the various stage of development obtained separately shows that human 
folliculogenesis in vitro is possible. The long time required for follicle development 
(Gougeon et al., 1987) and the dense ovarian stroma make this culture more challenging 
(Hovatta et al., 1997; Lass et al., 1997).  
Under the last ten years multiple studies regarding culture of fresh and 
cryopreserved ovarian tissue tried to discover and establish the perfect conditions to 
lead to complete and successful in vitro follicle development.  
In Humans several works described ovarian follicles growth from a state to the 
following state. Some develop techniques using preantral follicles isolated mechanically 
(Abir et al., 1997) or by enzymatic digestion (Roy and Tracy, 1993) that after culture 
observed antral cavity formation. However those achievements were hardly reproduce 
with primordial and primary follicles (Abir et al., 1999; Hovatta et al., 1999), showing 
that for this type of follicles the culture within ovarian tissue is recommended (Hovatta 
et al., 1997, 1999; Hreinsson et al., 2002; Scott et al:, 2004).   
 Recently a team reported a two-step culture (Telfer et al., 2008), trying to 
reproduce the good achievements obtained with this technique in mice (Eppig and 
O’Brien, 1996; O’Brien et al., 2003). In this protocol the small follicles, were in a first 
time cultured within a thin slice of ovarian tissue until they reach the secondary state. 
From there, the secondary follicles obtained were mechanically isolated and cultured 
until antral cavity formation was observed (Telfer et al., 2008).  The particularity of 
this study is the short time need to all this process (10 days), and the largest diameter 
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obtained for follicles cultured in a medium with activin A than in follicles cultured 
without this additional factor. 
 The addition of different growth factors and/or hormones in the culture medium 
as been study trying to improve the development and survival of the follicles in vitro 
(Wright et al., 1999; Louhio et al., 2000; Hreinsson et al., 2002; Telfer et al., 2008).  
 Among the factors that are pointed to regulate the initiation and progression of 
primordial development, Kit Lingand (KL) and b-fibroblast growth factor (bFGF) seem to 
be essential for their progression to primary follicles (Parrot and Skinner, 1999; Nilsson 
and al., 2004) while GDF-9 are fundamental to their development into the secondary 
stage (Hreinsson et al., 2002). Insulin, insulin like growth factor I (IGFI) and IGFII act as 
trophic factors for follicles and simultaneously stimulate follicular growth (Fabbri et al., 
2006; Louhio et al., 2000) and gonadotropins, FSH and LH are essential for progression 
from the preantral to the antral follicle stage (Wrigth et al., 1999). 
 The utilization of an extracellular matrix in the culture of isolated follicles to 
mimics the ovarian conditions were described successful (Roy and Treacy, 1993; Abir et 
al., 1999, 2001; Woodruff and Shea, 2007) but Telfer shows that it is not essential to 
obtained follicle growth (Telfer et al., 2008). 
 The presence or absence of serum in the culture medium is equally discussed 
with follicular growth observed in the two cases. 
Although all progress made in the culture of human follicles, this reality and 
clinical application is still far from the optimum conditions. Further experimentation is 
needed to fully understand the entire continuum of follicle development, optimize 
timings of exposure to key factors and to evaluate the viability of oocytes obtained to 
be fertilized and develop into normal embryo. 
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AIMS OF OUR STUDY 
 While most of previously works were realized on fresh ovarian tissue, the clinical 
reality is the future utilization of cryopreserved ovarian tissue, being important to 
realize and evaluate culture of cryopreserved ovarian tissue.  
 The aim of our study was to analyze the effect of two growth factors added into 
medium, evaluating 4 parameters of the follicle growth. 
 To accomplish it we realized: 
 Culture of human cryopreserved tissue simultaneously in three different 
culture media  
 Counting and morphological analyze of follicles 
 Observation of eventually changes in the morphological aspect of the 
stromal and vascular tissue into the ovarian fragments, along the culture 
 Immunohistochemical analyze of the follicles, stromal and vascular tissue  
using two markers involved in apoptosis (p53 and bcl2) and one marker of 
cell proliferation (Ki67) 
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MATERIALS AND METHODS 
OVARIAN TISSUE 
Human ovarian fragments frozen for fertility preservation of one 15 years old 
patient were used. 
The patient and her parents, before cryopreservation, signed an agreement for 
postmortem utilization, for research, of the frozen tissue. 
The isolated ovarian cortex has been cryopreserved as little fragments of about 
0,5 cm3 following the slow freezing method described by Gosden (Gosden et al., 1994) 
using DMSO  and sucrose as cryoprotectants. 
All manipulation of the human ovarian tissue was done with sterile material and 
under sterile conditions. 
OVARIAN TISSUE THAWING 
The ovarian fragments were thawed one by one as follow. 
The cryovial was pull out of the liquid nitrogen and placed for a few seconds at 
room temperature followed by five minutes in the incubator at 37ºC, till complete 
defrost of the cryopreservation medium. 
After this process the fragment was washed, at room temperature, successively 
in 4 different solutions containing a decreasing concentration of DMSO (2M; 1,5M; 1M; 
0M). The thawing solutions were composed by Leibovitz medium (Eurobio®, 
Courtaboeuf, France), DMSO (Sigma Aldrich®, St Quentin Fallavier, France), fetal calf 
serum (FCS) (Eurobio®) and 0.2M sucrose (Sigma Aldrich®). 
PREPARATION OF CORTICAL TISSUE FOR CULTURE  
After thawing the fragments were placed in a prewarmed Leibovitz medium 
(Eurobio®) supplemented with sodium pyruvate (2mM,), bovine serum albumin, BSA, 
(Fraction V, 3mg/mL), ascorbic acid (50 µg/mL,) and stabilized solution of L-Glutamin,  
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penicillin G and streptomycin (2mM, 75µg/mL, 50 µg/mL, respectively) all purchased 
from Sigma-Aldrich®.  
In this medium the fragments were cut into smaller pieces (~ 0,5 mm3) with a 
scalpel under a stereo microscope and pulled mechanically with 25 gauges needles 
(Sherwood médical®, Evry, France) to flatten out the tissue and to minimize the 
underlying stromal tissue. 
DIFFERENT CULTURE MEDIA COMPOSITION 
For this work three different culture media were used. 
The medium used as control group  was composed of McCoy’s 5a medium (Sigma-
Aldrich®) supplemented with HEPES (20mM, Eurobio®), BSA (0,1%), stabilized solution 
of L-Glutamin, penicillin G and streptomycin (3mM; 0,1mg/mL; 0,1g/mL, respectively), 
transferrin (2,5µg/mL), selenium (4ng/mL), insulin (10ng/mL) and ascorbic acid 
(50µg/mL), all purchased in Sigma Aldrich®. 
The two other media were composed by the control medium which has been 
supplemented with 200ng/mL of GDF-9(CliniSciences®, Montrouge, France) or with 
100ng/mL of activin A (R&D Systems®, Lille, France).  
The different culture medium gave name for the different groups, so there were 
formed 3 groups: 
 C group – control culture medium 
 G group – culture medium with GDF9 
 A group – culture medium with activin A 
CORTICAL STRIP CULTURE 
This work was accomplished in four different time cultures. 
The cortical strips were cultured individually in 24-well culture plates 
(Costar®,), containing 300 µL of the respectively culture medium, using a culture plate 
for each medium.  
The three groups are incubated (at the same time) at 37°C in humidified air with 
5% CO2. Half of the medium, of each well, was changed every 2 days. This pulled 
medium was stored at -20°C for further hormonal dosing.  
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Along the culture the strips were observed at the inverted light microscope, to 
verify the presence of developing follicles. 
A total of 247 cortical strips were cultured (82 in the control group; 82 in the 
GDF-9 group and 83 in the activin A group). 
HISTOLOGICAL ANALYSIS 
Before placing the cortical strips in the different culture media, 4-8 strips (from 
each fragment used), were fixed in a 10% formaldehyde solution overnight. 
At day 5, 10 and 14, of culture, eight strips of each group were fixed in a 10% 
formaldehyde solution overnight.  
At each time of fixation the strips of the same medium were fixed together. 
After fixation with 10% formaldehyde the samples were dehydrated in ethanol, 
using increase purity baths (70%, 90% and 100%). The absolute alcohol was then replaced 
by xylene and followed by paraffin inclusion of the samples. 
The blocks were sectioned manually at the microtome (3 or 4µm), mounted on 
charged slides and left to dry for at least one night at 37ºC. Each slide contained 2 or 3 
serial sections. 
MORPHOLOGICAL ANALYSIS 
For this analysis the serial sections obtained were staining with haematoxylin, 
eosine and safranin (HES). 
Every section in the slide was examined, by screening, to make the counting, 
morphological classification and evaluation of the follicles and intuitive evaluation of 
the stromal and vascular tissue.  
Follicle Counting and Classification 
The global counting of follicles includes all follicles observed, but for the 
classification only follicles with visible nucleus were counted, for evaluation of all 
parameters of the oocyte. The sections with visible nucleolus were chosen in 
preference. 
The follicles were classified as follow (Table 2).  
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Table 2: Characteristics observed and follicle stage associated 
FOLLICULAR STAGE CHARACTERISTICS 
Primordial Oocyte surrounded by one layer of flattened GCs 
Early primary Oocyte surrounded by one layer of flattened and cuboidal GCs 
Primary Oocyte surrounded by one layer of cuboidal GCs 
Secondary Oocyte surrounded by two or more layers of cuboidal GCs 
Others evaluation criteria 
The morphological evaluation of follicles was made only in the classified follicles 
by counting the GC’s, observing chromatin distribution (diffuse/dense) and oocyte 
cytoplasm configuration (normal/vacuolar/retracted). 
IMMUNOHISTOCHEMICAL EVALUATION  
The immunohistochemical staining was performed by an automated 
immunohistochemical processor (Benchmark XT, Ventana®, Illkirch, France) using HRP 
(horsedarish peroxidase) as reactive and DAB (diaminobenzidine tetrahydrochloride). 
The counterstaining was realized with haematoxylin II, all reagents were purchased in 
Ventana®.  
The primary antibodies used were monoclonal mouse anti-Human Ki67 (clone 
MIB-1) 1/50 diluted, p53 (clone DO-7) 1/25 diluted and Bcl2 (clone 124) 1/50 diluted, all 
obtained in Dako®, Trappes, France. 
The immunostaining was considered positive when the cells were observed with 
brown coloration, for all antibodies, and negative when cells observed are blue. 
Immunohistochemical evaluation of follicle was realized counting the number of 
GC’s positively marked versus GC’s negatively marked. 
Stroma and vascular cells marked positively were counted. 
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STATISTICAL ANALYSIS 
Quantitative values were treated with ANOVA with effect medium/day of 
culture. 
Binary variable were treated with logistic model with effect medium/day and 
interceptions within it. 
Ordinal variables were treated with logistic model ordinal with 3 or 2 modalities. 
For all tests the significatif value considered was p<0.05. 
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RESULTS 
MORPHOLOGICAL ANALYSIS 
Follicle Counting and Classification 
For this analyze 46 slides with each 2 or 3 serial sections of 8 grouped strips were 
observed.  
The counting of all follicles show a significant (p< 0.05) decrease in the number 
of follicles observed since the day 10 of culture for all culture media (Fig 7).  
Even if the different culture media did not present a significant difference it was 
observed a higher number of follicles in the G group. At the end of the culture this was 
the group with a higher number of follicles and a lower proportion of degenerate 
follicles. 
 
 
 
 
 
Figure 7: Total number (n) of follicles counted for each culture media at the different time of culture  
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Throughout the culture three types of follicles, primordial, early primary and 
primary were observed (Fig 8).  
 
 
 
 
 
 
 
 
 
 
 
The distribution of the different types of follicles varies in the three culture 
media and throughout the time but without significant difference and no evidence of 
follicle growth (Fig 9). 
 Histological sections of the cortical strips (n=28) fixed after thawing (not 
cultured) showed 57 follicles, distributed in 12 strips, where follicles were visualized. 
According to our counting method, from these follicles, only 31 were classifiable in the 
different stages (19 primordial, 3 early primary and 9 primary).  
 At the 5th day of culture, in the obtained sections, an increase of the 
proportion of early primary and primary stage were registered, especially in the GDF-9 
group (G) where 65% of the classifiable follicles were at the early primary stage. The 
activin A group (A) present the higher proportion of primary follicles (42% vs 12% for G 
and 33% for the control group (C) and 30% for not cultured). The primordial stage of 
development appears, at this time, in low number in the three culture media. 
A B 
Figure 8: Microscopy visualization of a histological section with HES staining of primordial follicle and  
  primary follicle (A)  and early primary follicles (B),in ovarian cortical strip. 
               Indicates the cuboidal cells;          Indicates the flattened cells 
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 At the 10th day of culture only 13 of the observed follicles were 
classifiable, and were equally distributed in the three groups. The observation of the 
histological sections showed an increased of the primary follicles for de G group and a 
decrease of the proportion of early primary follicles in the same day, compared with 
the 5th day of culture. For the others two culture media, the number of the three 
different types of follicles (primordial, early primary and primary) observed decreased 
comparing to the 5th Day but a similar proportional expression was registered.  
 After 14 days of culture only a few number of follicles were classified 
(7), with the presence of one follicle for the C and the A groups (primary and early 
respectively). The five remainder follicles were observed in the G group and were 
distributed among the 3 types of follicles with proportions that are close to those found 
at the 5th Day. 
In all sections analyzed no secondary follicles were seen. 
Figure 9: Distribution of the different types of follicles observed during the culture, for the three 
   culture media, and for the not cultured ovarian fragments  
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Others evaluation criteria 
The average of granulosa cells that surrounded the oocyte forming the follicle 
presents small variations in each medium during the culture (Table 3). However in the 
10th day of culture the G group shows a mean of 11 GCs for each follicle instead of the 7 
observed at the 5th day of culture. In the opposite the activin A group at the end of the 
culture only presented 3 GCs. 
Table 3: Average number of granulosa cells per follicle, calculated, by the histological counting of granulosa 
cells surrounding classifiable follicles, for each culture media at the different times of culture, and for not 
cultured follicles  
   5th Day  10th Day  14th Day 
 Not  
Cultured 
 
C G A 
 
C G A 
 
C G A 
GC/foll (n) 7  5 7 5  6 11 5  6 7 3 
 
The chromatin configuration and the cytoplasm aspect are morphological 
markers of the oocyte quality.  
The variations observed throughout the culture are shown in the table 4. 
Highlighting that, the normal aspect of the cytoplasm was mostly observed at the not 
cultured follicles, or in the follicles that were cultured only for 5 days. However, only at 
the end of the culture we register a higher proportion of retracted cytoplasm. In 
generality, we observe that in this culture, the oocyte presents a vacuolar cytoplasm. 
Table 4: Proportion of the different aspects of the cytoplasm in the oocytes observed, for each culture 
media and at different times of culture, and for not cultured follicles 
   5th Day  10th Day  14th Day 
 Not 
Cultured 
 
C G A  C G A  C G A 
Normal (%) 16,1  0 17,6 16,7  0 0 0  0 0 0 
Vacuolar (%) 61,3  66,7 58,8 66,7  100 75,0 40,0  100 40,0 0 
Retracted (%) 22,6  33,3 23,5 16,6  0 25,0 60,0  0 60,0 100 
Results 
Biology Department 
University of Aveiro                                                                                                               33 
The proportion of oocyte with dense or diffuse chromatin didn’t differ in the not 
cultured oocyte, however after 5 days of culture it was observed a higher proportion of 
oocyte with diffuse configuration of chromatin. This behavior was inverted at the 10th 
day of culture for the C and G groups that have a higher proportion of oocytes with 
dense chromatin. At the end of the culture only the G group shows oocytes with dense 
chromatin, however the observation for the C and A groups was made on a single oocyte 
for each group (Table 5). 
DEGENERATED/ATRETIC FOLLICLES 
For calculate the proportion of the degenerating follicles we used as total 
follicle population the classifiable, no classifiable and degenerating follicles (Fig 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Proportion of the follicles with a diffuse or a dense chromatin configuration, for the not cultured 
follicles and those cultured in the different culture media, at different time of the culture 
   5th Day  10th Day  14th Day 
 Not 
Cultured 
 C G A  C G A  C G A 
Diffuse (%) 48,3  100 82,3 91,2  25,0 25,0 75,0  100 40,0 100 
Dense (%) 51,7  0 17,7 8,8  75,0 75,0 25,0  0 60,0 0 
Figure 10: HES histological section of a primary and a  
   degenerating follicle of not cultured strips; 
   original magnification X 400 
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After 5 days of culture the three groups present a higher proportion of 
degenerated follicles when compared with the not cultured follicles (Fig 11). Along the 
culture time the difference between the groups increase. After 10 days of culture the A 
group present the higher proportion of degenerating follicles (58%) and the G group the 
lower proportion (25%) (p<0,001). The proportion of degenerated follicles observed was 
higher at the end of the culture, for the three groups (Fig 11). 
This is the only parameter where a real difference was observed between the 
different culture media and the time of culture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The deterioration of the tissue observed during the culture was confirmed by the 
histological analysis, with a badly quality of stroma and vessels at the 14th day of 
culture (Fig 12), and a low quantity of follicles visualized at this time of culture.  
 
 
Figure 11 : Proportion of degenerating follicles counted in the different culture media,    
    at different times of culture and in not cultured strips 
Figure 12 : HES sections of cultured stroma after 5 days of culture (A) and 14   
                  days of culture 
A B 
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IMMUNOHISTOCHEMICAL ANALYSIS 
For the immunohistochemicals markers the type of follicle was not a criterion for 
counting GCs, thus all GCs of all follicles were counted. Thus, follicles with or without a 
nucleus were counted. Nevertheless and as the previously parameters the screening 
observation was made being attention to not count twice the same follicle. 
Apoptotic markers (P53 and Bcl2) 
The number of follicles counted in those sections show, as the HES slides, the 
diminution of the number of follicles along the culture and consequently the number or 
GCs. 
The number of granulosa cells positively marked with p53 (Fig 13) observed was 
changing for the three media and at the different times of culture (Table 6) without a 
real tendency of the proportion of positive cells. In the not cultured strips none 
positively marked cells was visualized. 
 
At the end of the culture we observe only one follicle in the A group and the C 
group, with all GCs marked positively for the first and none for the C group.  
Except the 14th day of culture the group with less cells positively marked was the 
G group. It is also in this group that we counted more cells and more follicles. 
 
 
Figure 13: Cells staining brown are positively marked, cells staining blue are 
     negatively marked to the p53 
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The cells of the stromal and vascular tissue positively marked were also register, 
but no counting of not marked cell was done. The frequency of cells of those tissue 
marked were low and no depended medium and time of culture was verified. We just 
observe that generally for the three media and at all time of culture the vessels have 
more cells positively marked than in the stromal tissue. 
For the Bcl2 we didn’t observed granulosa cells positively marked. The only 
positive cells marked were cells of the vessels, but in a very low number. 
Proliferation marker (Ki67) 
In the sections obtained a low number of cells positively marked (Fig 14) were 
found for all the culture media with the trend of decreasing number of follicles 
depending on the time of culture, previously verified in the apoptotic markers and HES 
staining.  
 
 
 
 
 
Table 6: Follicle counting and proportions of positive granulosa cells marked for p53 antigene in a total of GCs in 
the three culture media, during the culture and in the not cultured strips 
   5th Day  10th Day  14th Day 
 Not Cultured 
 C G A  C G A  C G A 
+ GCs (%) 0  50 48,5 65,7  58,8 26,7 47,8  0 40,1 100 
Total GCs (n) 91  64 194 102  17 90 23  5 22 2 
Follicles (n) 14  11 34 19  3 13 7  1 5 1 
Figure 14: GCs marked for Ki67, cells staining brown are positive and cells   
               staining blue are negative 
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Excepting the 10th of culture the G and C groups have similar proportions of 
positive cell markers and in the total counted follicles (n=37 vs n=30, respectively. In 
opposition the A group represents the lower proportion of positive GCs, of total GCs and 
follicles (Table 7). 
The cells of the stromal and vascular tissue positively marked were also register, 
but no counting of not marked cell was done. The frequency of cells of those tissue 
marked were low but seems to be time depended, with more positively cells marked at 
the 5th day of culture for all groups, for both type of tissue.  
Except the G group, where we verified a high number of cells of the stroma 
positively marked after 10 days of culture, in the 10th and 14th day of culture a high 
decrease of the cells marked was observed.  
 
 
 
 
 
 
 
 
 
 
 
Table 7: Follicle counting and proportions of positive granulosa cells marked for Ki67 antigen in a total of GCs in 
the three culture media, during the culture and in the not cultured strips 
   5th Day  10th Day  14th Day 
 Not Cultured 
 C G A  C G A  C G A 
+ GCs (%) 2,5  20,6 21,7 13,1  11,1 22,6 5,9 16,7 14,9 0 
Total GCs (n) 119  126 180 99  63 31 17 18 47 5 
Follicles (n) 17  16 27 14  10 5 5 4 5 1 
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DISCUSSION 
The survival rate of young patients after chemotherapy and/or radiotherapy has 
improved in the last decades. Thus, the gonadotoxic effect of these treatments became 
a relevant issue, namely the premature ovarian failure, being important to preserve 
fertility of those patients.  
The cryopreservation of the ovarian tissue is a fertility preservation method and 
is the only one that can be proposed to prepubertal girls (Poirot et al., 2007). 
Nevertheless, in the ovary the oocytes are immature being necessary to induce their 
maturation for further fertilization. 
The transplantation of the cryopreserved tissue is the currently technique to 
maturate those oocytes. However, with transplantation and for some diseases there is a 
great risk of reintroduction of malignant cells, thus the maturation in vitro is the goal. 
For the last 20 years multiply studies concerning the in vitro growth of follicles 
were executed using animal models and more recently using ovarian tissue, mostly with 
fresh ovarian tissue. 
Conversely the clinical application will be with cryopreserved tissue, that’s why 
we chose to only use cryopreserved tissue for our study.  
Recently, a study report the efficacy of a two steps culture of ovarian tissue to 
obtain small antral follicles in a short time (10 days) (Telfer et al., 2008). In this study 
developing follicles were obtained in a serum free medium and without matrix support, 
after a culture of cortical tissue, during 6 days, followed by the isolation and culture of 
preantral follicles. The second step of this culture (culture of isolated follicles), was a 
comparative study of the effect of activin A in human folliculogenesis, since the same 
author has demonstrated that this protein, produced in the granulosa cells, have a 
proliferating effect in the preantral bovine follicles (Thomas et al., 2003). 
Since we didn’t find studies revealing an inhibitory effect of activin A in the 
culture of ovarian tissue, and that the precise stage of action of activin A is 
controversial (Zhao et al., 2001) we decided to used this protein since the beginning of 
the culture.  
Indeed we decided to develop a work comparing three culture media, using 
activin A and GDF-9. The medium used previously by Telfer (Telfer et al., 2008) to 
perform the culture of cortical strips were used as control, and to this medium we 
added activin A or GDF-9. The choice of GDF-9 was due to a positive effect on the 
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growth and development of secondary follicles, in a culture of fresh human tissue 
previously demonstrated (Hreinsson et al., 2002).  
With this study we wanted to evaluate differences in parameters of follicular 
growth and development for the three culture media and thus the effects of GDF9 and 
activin A in the ovarian follicles developing in vitro. 
We decided to extend the culture to 14 days instead of the 6 days as Telfer, 
since the observation of the cortical strips in culture, didn’t allowed to detect the 
presence of secondary follicles for isolation and in this way we could evaluate the 
possible developing of the follicles in the tissue, in vitro.  
In this work the proportion of the different types of follicles seems to be 
independent of the culture media. Nevertheless the diminished number of primordial 
follicles counted, for the G group, the increase of early primary follicles after 5 days of 
culture and the counting of more primary follicles in the 10th day of culture suggest that 
during those 10 days of culture with this culture medium a follicular development 
occur. Hreinsoon showed a higher proportion of secondary follicles after 7 days of fresh 
ovarian tissue culture in a medium with GDF-9, but also with human serum albumin 
(HSA).  
In the 5th day of culture the presence of follicles, in the G group, was confirmed 
by visual observation of follicles in the cortical strips (Fig 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 15 : General view, with the inverted microscope (200X) of follicles in a cortical strip, in the GDF-9 medium, at   
     the 5th Day (A) and of one follicle in the peripheral zone (B) 
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The higher number of follicles and GCs counted, the lower proportion of 
degenerating follicles (15% at day 5, 25% for 10th day and 41% at the end of the culture) 
in the G group, corroborates the previously results that indicate this growth factor as a 
survival factor (Hreinsson et al., 2002). 
In the culture of preantral follicles the activin A was also indicated as a survival 
factor (Telfer et al., 2008), that is not verified in the present study in which higher 
proportion of atretic follicles was registered and a global follicular counting diminuished 
at the end of the culture, for the A group.  
The total population counting of follicles included the degenerate follicles and 
still the number of follicles observed along the culture decrease for the three culture 
media showing a described phenomenon and that happens in vivo too, the reabsorption 
by the stromal tissue of the atretic follicles.  
The expression of p53 revealed that cells present DNA damage and as cell cycle 
regulator the overexpression of this protein will induce the arrest of the cell cycle at 
the G1 phase, inducing the cells arrest development and death. 
Our study reveals a variable expression of p53 over the time culture and the 
different culture media, but the expression of this protein indicates that DNA damages 
were present. For this marker the G group exhibits the lower proportion of positive 
cells, in the presence of the higher number of cells and follicles, evidencing that maybe 
with this medium the cells have less DNA anomalies and consequently lower expression 
of p53. A positive marking was also seen in oocyte nucleolus, cells of the stroma and 
cells of the vessels, showing that not only the follicular cells are damaged but also the 
other type of cells. The obtained results differs of those obtained by Depalo (Depalo et 
al., 2003), that concludes in her study that the apoptosis process in the earliest stages 
of follicular development is a cell autonomous physiological event independent of 
changes in the ovarian medium and not as a consequence of changes or alterations in 
the cell genome and that occurs first in the GCs and then in the oocyte. However her 
study was in not cultured fresh ovarian tissue, thus the present results obtained might 
proved that culture changes cell genome.  
The Bcl2 is an anti-apoptotic regulator, providing protection against cell death 
and have normally an inverse expression of p53 (Depalo et al., 2003). So its absence 
reveals that those cells have none response capacity to avoid the cell death, sentencing 
cells to death. This corroborates the finding results of Depalo that demonstrate that 
Bcl2 was not expressed in the GCs of primordial and primary follicles. 
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The Ki67 is a nuclear antigen expressed in all phases of the cell cycle except G0, 
so Ki67 expression reveals cell division activity, so it was expected that during the 
culture his expression increase, which didn’t occur in our study. The expression of Ki67 
to the contrary decreased along the time for all culture media. The staining of stroma 
cells were low, indicating that proliferation of this tissue didn’t happen, and that it was 
probably due to the culture medium, since Fabbri (Fabbri et al., 2003) proved that 
cryopreservation didn’t change capacity of cell proliferation expression with Ki67.  
The proportion of p53 cells positively marked was higher than the proportion of 
Ki67 cells positively marked demonstrating that in our cultures apoptosis was in higher 
proportion that cell proliferation.  
In this present work the results obtained were very different of those obtained 
for fresh tissue, using similar protocols (Telfer et al., 2008; Hreisson et al., 2002), since 
both obtained secondary developed follicles after 6 and 7 days of culture respectively. 
Thus it seems that culture of cryopreserved tissue has different evolution and maybe 
different needs from those of fresh tissue. On the other hand comparative studies have 
demonstrated no significant difference in the density and proportion of follicles 
between fresh and cryopreserved ovarian tissue (Hovatta et al., 1997; Schubert et al., 
2005). 
The time of culture, the presence or absence of serum and/or a support matrix, 
effects in ovarian tissue culture have been reported but without consensus of the better 
system (Hovatta et al., 1997; Hreisson et al., 2002; Sadeu et al., 2008; Telfer et al., 
2008). Further studies, specially using cryopreserved ovarian tissue are needed to 
efficiently the culture and the development of primordial follicles. 
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CONCLUSION AND PERSPECTIVES 
The cortical tissue contains a non renewable quantity of follicles and their 
oocytes. For women treated for cancer and which fertility is in danger, culturing this 
tissue under conditions that promote viable mature follicles without risking 
reintroduction of malignant cells is an very important goal.  
 At the moment several studies allowed follicular development in vitro, at least 
of a determinant stage of development to the immediately superior (Roy and Tracy, 
1993; Abir et al., 1997;  Hovatta et al., 1997, 1999; Abir et al., 1999; , Hreinsson et al., 
2002; Scott et al, 2004). 
The primordial recruitment and his development into the Graafian stage, 
changes of requirements of the cells, cellular interactions and morphogenesis are major 
challenges for contemporary cell culture technology. 
With this work we show, that after thawing, a decrease of follicular population 
for the three culture medium, and a higher proportion of degenerating follicles in the 
Activin A group, in the opposite the GDF-9 group present the lower proportion, 
confirming the GDF-9 survival role in culture, results corroborate by the lower 
proportion of GCs positively marked for apoptotic marker p53. 
In the opposite we observed that activin A seems to have a negative effect in the 
earliest stage of follicular development in human.  
 
Further studies for improve the culture medium with the proteins used in the 
present study and with others as kit Lingand, adapted to the different time of follicular 
development are pertinent as well as different types of culture.  
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APPENDIX 
CHEMICALS  
Chemical Supplier Catalog Nº 
Activin A  R&D Systems 338 AC 
Ascorbic acid  Sigma A4403 
BSA  Sigma A9418 
DMSO Sigma D2650 
FCS EuroBio CVFSVF040U 
GDF 9 CliniSciences 4872 
HEPES  EuroBio CSTHP000P 
Insulin  Sigma I2643 
L-15  EuroBio CM1L15000U 
McCoy’s 5a Sigma M8403 
PBS EuroBio CS1PBS000U 
PSG Sigma G6784 
Pyruvate sodium Sigma P5280 
Selenium Sigma S5261 
Sucrose Sigma S7903 
Transferrin Sigma T8158 
The powder chemicals were solubilized with PBS 
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SOLUTIONS 
THAWING SOLUTIONS 
 L15 DMSO SVF Sucrose  
Solution 1 3,9 mL 0,5 mL 0,5 mL 0,1 mL 
Solution 2 4,0 mL 0,4 mL 0,5 mL 0,1 mL 
Solution 3 4,2 mL 0,2 mL 0,5 mL 0,1 mL 
Solution 4 4 mL  1 mL  
 
DISSECTION MEDIUM 
 
Initial 
concentration 
Concentration 
needed 
Vol/mL 
L-15   910 µL 
BSA 40 mg/mL 3 mg/mL 75 µL 
Pyruvate sodium 1 M 2mM 2 µL 
PSG   10 µL 
Ascorbic acid 10 mg/mL 50 µg/mL 5 µL 
 
CULTURE MEDIUM 
 
Initial  
concentration 
Concentration  
needed Vol/ mL 
McCoy’s   950 µL 
BSA 40 mg/mL 0,1% 1 µL 
HEPES 1 M 20 mM 20 µL 
PSG   15 µL 
Insulin * 2 mg/mL 10 ng/mL 1µL 
Transferrin * 10 mg/mL 2,5 µg/mL 5 µL 
Selenium * 1 mg/mL 4 ng/mL 2 µL 
Ascorbic acid 10 mg/mL 50 µg/mL 5 µL 
Activin A 10 µg/mL 100 ng/mL 10 µL 
GDF 9 100 µg/mL 200 ng/mL 2 µL 
*For those reagents dilutions were made due to the lower volume needed 
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Date mise en culture :      Jour de fixation : 
Nº DE LA LAME : 
HES 
 
COUPES 
CYTOPLASMIQUES 
 COUPES 
POLAIRES  
FOLL. 
DEGEN. 
ETAT DES PAROIS 
VASCULAIRES  
ASPECT DU 
STROMA 
 
 
    
 
OBSERVATIONS :  
ASPECT DU 
CYTOPLASME NUCLEOLE CHROMATINE 
Nº 
CELL. FOLLI. 
TYPE DE 
FOLLICULE 
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
P53 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
TYPE DE FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
Ki 67 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
  
TYPE DE 
FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
Bcl 2 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
 
 
 
 
 
 
 
TYPE DE 
FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
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AGREEMENT FOR OVARIAN TISSUE CRYOPRESERVATION 
 For minors patients  
 
 
Groupe Hospitalier Pitié-Salpêtrière 
UF de Biologie de la Reproduction,  
Pr Catherine Poirot 
83, bd de l'Hôpital de la Pitié-Salpétrière 75013 Paris.  Tél : 01 42 17 75 50 
 
 
 
 
FORMULAIRE DE CONSENTEMENT POUR UNE PATIENTE MINEURE 
DEVANT BENEFICIER D’UNE CRYOCONSERVATION DE CORTEX 
OVARIEN 
 
 
 
 
 Madame, Monsieur, 
 
 
La maladie de votre fille nécessite un traitement qui peut perturber le fonctionnement des 
ovaires et en conséquence, la possibilité d’avoir des enfants. Pour préserver sa fonction 
ovarienne et sa fertilité, nous vous proposons de prélever et de conserver par congélation 
du tissu ovarien de votre fille.  
 
Actuellement, plusieurs centaines de femmes et d’enfants ont déjà bénéficié d’une 
congélation de tissu ovarien. Pour le moment, quelques enfants sont nés après 
décongélation et greffe de tissu ovarien.  
 
Malgré tout, ces techniques sont encore récentes et nous ne pouvons pas garantir leur 
efficacité.  
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Après les différentes consultations médicales, si vous acceptez la cryoconservation du tissu 
ovarien de votre fille, les étapes spécifiques à cette prise en charge seront les suivantes:  
- un prélèvement de sang pour un bilan sérologique (hépatite B, hépatite C, VIH 1 et 
2, syphilis) et pour la préparation du milieu de congélation, 
- une intervention chirurgicale sous anesthésie générale pour effectuer le 
prélèvement de tissu ovarien,  
- ensuite le tissu ovarien sera préparé, congelé et conservé dans l’azote liquide 
jusqu’à utilisation,  
- au moment de cette cryoconservation, un examen microscopique sur un fragment 
du tissu permettra d'identifier les différentes cellules présentes. 
 
 
 
 
 
 
 
Nous soussignés,  
 
Madame, ………...………..………..…..née le 
……………………..à…………..…..…………………….. 
 
Monsieur, ……….…….…………..…….né le 
……………….……..à…………………………………….. 
 
Parents ou tuteur légal de : ………………………………née 
le :…………….à…………………………... 
demeurant………….………………………………………………………………….……
………………... 
………………………………………………………………………………………………
……………….. 
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certifions accepter une cryoconservation du tissu ovarien de notre fille conformément à 
l’article L.2141-11 de la loi n° 2004-800 du 06/08/2004 et l’article R.2142-29, décret n° 
2006-1660 du 22/12/2006, avoir été informés et accepter les points suivants :  
 
- Nous avons bien compris que le laboratoire ne peut pas garantir la capacité du tissu 
ovarien à retrouver ses fonctions,  
- La conservation du tissu ovarien de notre fille est renouvelable chaque année sur 
demande écrite. En conséquence, nous recevrons annuellement un courrier pour exprimer 
notre souhait de prolonger ou non la conservation, et nous nous engageons à y répondre. 
- Nous nous engageons à signaler tout changement d’adresse. 
 
 
La restitution du tissu ovarien de notre fille ne s’effectuera qu’en sa présence et avec son 
accord. Le type d’utilisation sera défini après concertation multidisciplinaire entre les 
différents médecins impliqués dans sa prise en charge (l’oncologue, l’hématologue et les 
gynécologues obstétriciens, les chirurgiens, les biologistes de la reproduction...). 
 
 
Dans l’hypothèse où notre fille n’aurait plus besoin de son tissu ovarien ou en cas de 
décès (1) : 
 
(1) veuillez cocher la case correspondant à votre choix 
 
   Nous souhaitons que son tissu ovarien soit détruit 
 
  Nous autorisons l'utilisation de son tissu ovarien à des fins de recherche 
 
 
Les informations concernant notre fille seront collectées et feront l’objet d’un traitement 
informatisé. Ces données demeurent strictement confidentielles et leur consultation ne sera 
faite que par des personnes astreintes au secret professionnel.  
 
Nous bénéficions, en outre, d'un droit d'accès et de rectification, aux informations la 
concernant (article 40 de la Loi "Informatique et Liberté"), celui-ci s'exerçant à tout 
moment, par l'intermédiaire du médecin de notre choix. Nous disposons également d'un 
droit d'opposition à la transmission des données couvertes par le secret professionnel. 
 
 
 
 
 
 
 
 
 
Fait à ……………………….. le……………………………    
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Le père de la patiente ou le tuteur   
  titulaire de l’autorité parentale                                              La patiente mineure 
 
 
Père, tuteur de l’enfant                                                                
Mademoiselle……………………………. 
 
Nom………………………………..                                           Nom 
……………………………………… 
 
Prénom……………………………..                                           
Prénom…………………………………… 
 
Signature obligatoire* :            Signature* : 
 
 
 
 
 
 
 
 
 
    La mère de la patiente                                                        Le médecin biologiste de la 
reproduction, 
 
titulaire de l’autorité parentale                                             Docteur, Professeur 
 
 
Madame,        Mademoiselle                                                           
Nom………………………………………. 
 
Nom………………………………..                                        
Prénom…………………………………….. 
 
Prénom……………………………..                                       Signature obligatoire : 
 
Signature obligatoire* : 
 
 
 
 
 
 
 
 
 
* Signature précédée de la mention « lu et approuvé » 
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APPENDIX 
CHEMICALS  
Chemical Supplier Catalog Nº 
Activin A  R&D Systems 338 AC 
Ascorbic acid  Sigma A4403 
BSA  Sigma A9418 
DMSO Sigma D2650 
FCS EuroBio CVFSVF040U 
GDF 9 CliniSciences 4872 
HEPES  EuroBio CSTHP000P 
Insulin  Sigma I2643 
L-15  EuroBio CM1L15000U 
McCoy’s 5a Sigma M8403 
PBS EuroBio CS1PBS000U 
PSG Sigma G6784 
Pyruvate sodium Sigma P5280 
Selenium Sigma S5261 
Sucrose Sigma S7903 
Transferrin Sigma T8158 
The powder chemicals were solubilized with PBS 
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SOLUTIONS 
THAWING SOLUTIONS 
 L15 DMSO SVF Sucrose  
Solution 1 3,9 mL 0,5 mL 0,5 mL 0,1 mL 
Solution 2 4,0 mL 0,4 mL 0,5 mL 0,1 mL 
Solution 3 4,2 mL 0,2 mL 0,5 mL 0,1 mL 
Solution 4 4 mL  1 mL  
 
DISSECTION MEDIUM 
 
Initial 
concentration 
Concentration 
needed 
Vol/mL 
L-15   910 µL 
BSA 40 mg/mL 3 mg/mL 75 µL 
Pyruvate sodium 1 M 2mM 2 µL 
PSG   10 µL 
Ascorbic acid 10 mg/mL 50 µg/mL 5 µL 
 
CULTURE MEDIUM 
 
Initial  
concentration 
Concentration  
needed Vol/ mL 
McCoy’s   950 µL 
BSA 40 mg/mL 0,1% 1 µL 
HEPES 1 M 20 mM 20 µL 
PSG   15 µL 
Insulin * 2 mg/mL 10 ng/mL 1µL 
Transferrin * 10 mg/mL 2,5 µg/mL 5 µL 
Selenium * 1 mg/mL 4 ng/mL 2 µL 
Ascorbic acid 10 mg/mL 50 µg/mL 5 µL 
Activin A 10 µg/mL 100 ng/mL 10 µL 
GDF 9 100 µg/mL 200 ng/mL 2 µL 
*For those reagents dilutions were made due to the lower volume needed 
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Date mise en culture :      Jour de fixation : 
Nº DE LA LAME : 
HES 
 
COUPES 
CYTOPLASMIQUES 
 COUPES 
POLAIRES  
FOLL. 
DEGEN. 
ETAT DES PAROIS 
VASCULAIRES  
ASPECT DU 
STROMA 
 
 
    
 
OBSERVATIONS :  
ASPECT DU  
CYTOPLASME  
NUCLEOLE CHROMATINE Nº 
CELL. FOLLI. 
TYPE DE 
FOLLICULE 
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
P53 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
TYPE DE 
FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
Ki 67 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
  
TYPE DE 
FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
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Date mise en culture :      Jour de fixation : 
Nº  DE LA LAME: 
Bcl 2 
 
 
 
 
 
 
 
OBSERVATIONS: 
 
 
 
 
 
 
 
 
 
 
 
 
TYPE DE 
FOLLICULE NOYAU 
N° CELL. FOLLI. 
+ - 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
CELLULES /200 
+ - 
STROMA   
 
CELLULES /100 
+ - 
VAISSEAUX    
Appendix 
 
Biology Department 
University of Aveiro 
AGREEMENT FOR OVARIAN CRYOPRESERVATION 
 For minors patients  
 
 
Groupe Hospitalier Pitié-Salpêtrière 
UF de Biologie de la Reproduction,  
Pr Catherine Poirot 
83, bd de l'Hôpital de la Pitié-Salpétrière 75013 Paris.  Tél : 01 42 17 75 50 
 
 
 
 
FORMULAIRE DE CONSENTEMENT POUR UNE PATIENTE MINEURE 
DEVANT BENEFICIER D’UNE CRYOCONSERVATION DE CORTEX 
OVARIEN 
 
 
 
 
 Madame, Monsieur, 
 
 
La maladie de votre fille nécessite un traitement qui peut perturber le fonctionnement des 
ovaires et en conséquence, la possibilité d’avoir des enfants. Pour préserver sa fonction 
ovarienne et sa fertilité, nous vous proposons de prélever et de conserver par congélation 
du tissu ovarien de votre fille.  
 
Actuellement, plusieurs centaines de femmes et d’enfants ont déjà bénéficié d’une 
congélation de tissu ovarien. Pour le moment, quelques enfants sont nés après 
décongélation et greffe de tissu ovarien.  
 
Malgré tout, ces techniques sont encore récentes et nous ne pouvons pas garantir leur 
efficacité.  
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Après les différentes consultations médicales, si vous acceptez la cryoconservation du tissu 
ovarien de votre fille, les étapes spécifiques à cette prise en charge seront les suivantes:  
- un prélèvement de sang pour un bilan sérologique (hépatite B, hépatite C, VIH 1 et 
2, syphilis) et pour la préparation du milieu de congélation, 
- une intervention chirurgicale sous anesthésie générale pour effectuer le 
prélèvement de tissu ovarien,  
- ensuite le tissu ovarien sera préparé, congelé et conservé dans l’azote liquide 
jusqu’à utilisation,  
- au moment de cette cryoconservation, un examen microscopique sur un fragment 
du tissu permettra d'identifier les différentes cellules présentes. 
 
 
 
 
 
 
 
Nous soussignés,  
 
Madame, ………...………..………..…..née le 
……………………..à…………..…..…………………….. 
 
Monsieur, ……….…….…………..…….né le 
……………….……..à…………………………………….. 
 
Parents ou tuteur légal de : ………………………………née 
le :…………….à…………………………... 
demeurant………….………………………………………………………………….……
………………... 
………………………………………………………………………………………………
……………….. 
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certifions accepter une cryoconservation du tissu ovarien de notre fille conformément à 
l’article L.2141-11 de la loi n° 2004-800 du 06/08/2004 et l’article R.2142-29, décret n° 
2006-1660 du 22/12/2006, avoir été informés et accepter les points suivants :  
 
- Nous avons bien compris que le laboratoire ne peut pas garantir la capacité du tissu 
ovarien à retrouver ses fonctions,  
- La conservation du tissu ovarien de notre fille est renouvelable chaque année sur 
demande écrite. En conséquence, nous recevrons annuellement un courrier pour exprimer 
notre souhait de prolonger ou non la conservation, et nous nous engageons à y répondre. 
- Nous nous engageons à signaler tout changement d’adresse. 
 
 
La restitution du tissu ovarien de notre fille ne s’effectuera qu’en sa présence et avec son 
accord. Le type d’utilisation sera défini après concertation multidisciplinaire entre les 
différents médecins impliqués dans sa prise en charge (l’oncologue, l’hématologue et les 
gynécologues obstétriciens, les chirurgiens, les biologistes de la reproduction...). 
 
 
Dans l’hypothèse où notre fille n’aurait plus besoin de son tissu ovarien ou en cas de 
décès (1) : 
 
(1) veuillez cocher la case correspondant à votre choix 
 
   Nous souhaitons que son tissu ovarien soit détruit 
 
  Nous autorisons l'utilisation de son tissu ovarien à des fins de recherche 
 
 
Les informations concernant notre fille seront collectées et feront l’objet d’un traitement 
informatisé. Ces données demeurent strictement confidentielles et leur consultation ne sera 
faite que par des personnes astreintes au secret professionnel.  
 
Nous bénéficions, en outre, d'un droit d'accès et de rectification, aux informations la 
concernant (article 40 de la Loi "Informatique et Liberté"), celui-ci s'exerçant à tout 
moment, par l'intermédiaire du médecin de notre choix. Nous disposons également d'un 
droit d'opposition à la transmission des données couvertes par le secret professionnel. 
 
 
 
 
 
 
 
 
 
Fait à ……………………….. le……………………………    
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Le père de la patiente ou le tuteur   
  titulaire de l’autorité parentale                                              La patiente mineure 
 
 
Père, tuteur de l’enfant                                                                
Mademoiselle……………………………. 
 
Nom………………………………..                                           Nom 
……………………………………… 
 
Prénom……………………………..                                           
Prénom…………………………………… 
 
Signature obligatoire* :            Signature* : 
 
 
 
 
 
 
 
 
 
    La mère de la patiente                                                        Le médecin biologiste de la 
reproduction, 
 
titulaire de l’autorité parentale                                             Docteur, Professeur 
 
 
Madame,        Mademoiselle                                                           
Nom………………………………………. 
 
Nom………………………………..                                        
Prénom…………………………………….. 
 
Prénom……………………………..                                       Signature obligatoire : 
 
Signature obligatoire* : 
 
 
 
 
 
 
 
 
 
* Signature précédée de la mention « lu et approuvé » 
